Feature Channels:

Pharmaceuticals

Add to Favorites Subscribe Share
fbshare-Pharmaceuticals

Showing results

110 of 3643
APS_Profile.jpg

Maternal Antibiotic Treatment May Harm Preemies’ Lungs

American Physiological Society (APS)

New research in mice suggests that exposure to antibiotics before birth may impair lung development in premature infants. The study, the first to explore the gut-lung axis in prematurity, is published ahead of print in the American Journal of Physiology—Lung Cellular and Molecular Physiology and was chosen as an APSselect article for December.

Channels: All Journal News, Children's Health, Pharmaceuticals, Respiratory Diseases and Disorders,

Released:
5-Dec-2019 1:50 PM EST
Open in New Tab
Embargo will expire:
9-Dec-2019 11:00 AM EST
Released to reporters:
5-Dec-2019 12:50 PM EST

EMBARGOED

A reporter's PressPass is required to access this story until the embargo expires on 9-Dec-2019 11:00 AM EST

The Newswise PressPass gives verified journalists access to embargoed stories. Please log in to complete a presspass application.
If you have not yet registered, please do so. When you fill out the registration form, please identify yourself as a reporter in order to advance to the presspass application form.

Research Results
Embargo will expire:
9-Dec-2019 11:00 AM EST
Released to reporters:
5-Dec-2019 12:25 PM EST

EMBARGOED

A reporter's PressPass is required to access this story until the embargo expires on 9-Dec-2019 11:00 AM EST

The Newswise PressPass gives verified journalists access to embargoed stories. Please log in to complete a presspass application.
If you have not yet registered, please do so. When you fill out the registration form, please identify yourself as a reporter in order to advance to the presspass application form.

Research Results
Embargo will expire:
7-Dec-2019 3:15 PM EST
Released to reporters:
5-Dec-2019 12:05 PM EST

EMBARGOED

A reporter's PressPass is required to access this story until the embargo expires on 7-Dec-2019 3:15 PM EST

The Newswise PressPass gives verified journalists access to embargoed stories. Please log in to complete a presspass application.
If you have not yet registered, please do so. When you fill out the registration form, please identify yourself as a reporter in order to advance to the presspass application form.

Research Results
Newswise: Common Diabetes Medications Tested for Anti-Aging Effects

Common Diabetes Medications Tested for Anti-Aging Effects

Texas Biomedical Research Institute

Two drugs already on the market to treat type two diabetes are being tested in nonhuman primates to see if they can impact the aging process. Researchers dosed marmosets with Metformin and Acarbose and found no adverse side effects

Channels: Aging, Diabetes, Healthcare, Pharmaceuticals, Grant Funded News,

Released:
4-Dec-2019 1:30 PM EST
Open in New Tab
Comment
Research Results
Embargo will expire:
9-Dec-2019 2:45 PM EST
Released to reporters:
4-Dec-2019 12:40 PM EST

EMBARGOED

A reporter's PressPass is required to access this story until the embargo expires on 9-Dec-2019 2:45 PM EST

The Newswise PressPass gives verified journalists access to embargoed stories. Please log in to complete a presspass application.
If you have not yet registered, please do so. When you fill out the registration form, please identify yourself as a reporter in order to advance to the presspass application form.

Research Results
BlueOneLineCancerCenterLogo.png

CicloMed Expands Fosciclopirox Phase 1 Trial to Include Cisplatin-Ineligible Muscle-Invasive Bladder Cancer Patients

University of Kansas Cancer Center

First patient enrolled at The University of Kansas Cancer Center in expansion cohort study characterizing the safety, pharmacokinetics and pharmacodynamics of fosciclopirox in bladder cancer patients

Channels: All Journal News, Cancer, Clinical Trials, Pharmaceuticals,

Released:
4-Dec-2019 12:35 PM EST
Open in New Tab
Comment
Research Results
Embargo will expire:
9-Dec-2019 10:30 AM EST
Released to reporters:
4-Dec-2019 12:30 PM EST

EMBARGOED

A reporter's PressPass is required to access this story until the embargo expires on 9-Dec-2019 10:30 AM EST

The Newswise PressPass gives verified journalists access to embargoed stories. Please log in to complete a presspass application.
If you have not yet registered, please do so. When you fill out the registration form, please identify yourself as a reporter in order to advance to the presspass application form.

Announcement
Embargo will expire:
9-Dec-2019 6:00 PM EST
Released to reporters:
4-Dec-2019 11:50 AM EST

EMBARGOED

A reporter's PressPass is required to access this story until the embargo expires on 9-Dec-2019 6:00 PM EST

The Newswise PressPass gives verified journalists access to embargoed stories. Please log in to complete a presspass application.
If you have not yet registered, please do so. When you fill out the registration form, please identify yourself as a reporter in order to advance to the presspass application form.

Research Results

Showing results

110 of 3643

Chat now!
29.81777